Skip to main content
. 2016 Oct 6;37(11):4148–4157. doi: 10.1002/hbm.23302

Figure 1.

Figure 1

Experimental design. In a within‐subject design, each participant either received placebo or 2 mg haloperidol on one of the days, with the assignment of haloperidol/placebo carried out in a randomized double‐blind manner. Resting‐state functional connectivity was assessed preceding pharmacological intervention (baseline sessions) and at the approximate peak level of plasma concentration of haloperidol (peak sessions).